Somewhat Positive Media Coverage Somewhat Unlikely to Affect Intuitive Surgical (NASDAQ:ISRG) Share Price

News coverage about Intuitive Surgical (NASDAQ:ISRG) has been trending somewhat positive recently, Accern Sentiment reports. The research firm identifies positive and negative news coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Intuitive Surgical earned a news impact score of 0.21 on Accern’s scale. Accern also assigned media stories about the medical equipment provider an impact score of 46.4641863307078 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

Here are some of the news articles that may have impacted Accern Sentiment’s analysis:

How to Become a New Pot Stock Millionaire

Shares of NASDAQ:ISRG opened at $406.12 on Friday. The company has a market capitalization of $45,441.92, a P/E ratio of 51.13, a price-to-earnings-growth ratio of 4.79 and a beta of 0.57. Intuitive Surgical has a 52 week low of $251.13 and a 52 week high of $452.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, January 25th. The medical equipment provider reported $2.54 EPS for the quarter, topping analysts’ consensus estimates of $2.27 by $0.27. Intuitive Surgical had a net margin of 21.09% and a return on equity of 19.93%. The company had revenue of $892.40 million during the quarter, compared to the consensus estimate of $866.54 million. During the same quarter in the previous year, the firm posted $2.03 earnings per share. Intuitive Surgical’s revenue for the quarter was up 17.9% compared to the same quarter last year. analysts forecast that Intuitive Surgical will post 7.85 EPS for the current fiscal year.

Several research analysts recently commented on ISRG shares. BidaskClub lowered Intuitive Surgical from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, December 12th. Vetr downgraded shares of Intuitive Surgical from a “strong-buy” rating to a “buy” rating and set a $455.31 price objective for the company. in a research note on Monday. Zacks Investment Research raised shares of Intuitive Surgical from a “hold” rating to a “strong-buy” rating and set a $437.00 price objective for the company in a research note on Tuesday, December 12th. Royal Bank of Canada raised their price objective on shares of Intuitive Surgical to $430.00 and gave the stock a “sector perform” rating in a research note on Friday, January 26th. Finally, Canaccord Genuity reissued a “hold” rating and issued a $410.00 price objective (up previously from $380.00) on shares of Intuitive Surgical in a research note on Friday, January 26th. They noted that the move was a valuation call. One investment analyst has rated the stock with a sell rating, six have issued a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the stock. The stock has a consensus rating of “Buy” and an average target price of $413.84.

In other Intuitive Surgical news, Director Mark J. Rubash sold 1,000 shares of Intuitive Surgical stock in a transaction on Monday, March 5th. The shares were sold at an average price of $420.01, for a total value of $420,010.00. Following the transaction, the director now directly owns 4,453 shares of the company’s stock, valued at $1,870,304.53. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Lonnie M. Smith sold 18,000 shares of Intuitive Surgical stock in a transaction on Tuesday, January 30th. The stock was sold at an average price of $428.68, for a total transaction of $7,716,240.00. Following the completion of the transaction, the director now directly owns 511,410 shares in the company, valued at $219,231,238.80. The disclosure for this sale can be found here. Insiders sold 102,770 shares of company stock worth $43,410,836 over the last ninety days. Corporate insiders own 2.20% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Somewhat Positive Media Coverage Somewhat Unlikely to Affect Intuitive Surgical (NASDAQ:ISRG) Share Price” was originally published by BBNS and is the property of of BBNS. If you are viewing this piece on another publication, it was copied illegally and republished in violation of US and international trademark & copyright legislation. The original version of this piece can be read at https://baseballnewssource.com/2018/04/06/intuitive-surgical-isrg-given-daily-media-sentiment-rating-of-0-21/2030794.html.

About Intuitive Surgical

Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company's da Vinci surgical System translates a surgeon's natural hand movements, which are performed on instrument controls at a console into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

Insider Buying and Selling by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Almora Jr. and Baez Could Become Cubs new One-Two Tandem
Almora Jr. and Baez Could Become Cubs new One-Two Tandem
Red Sox Tie Record for Best Start After 17 Games
Red Sox Tie Record for Best Start After 17 Games
Bryce Harper Hits 406-Foot Home Run While Breaking His Bat
Bryce Harper Hits 406-Foot Home Run While Breaking His Bat
Rick Porcello’s Strong Start Gives Boost to Red Sox
Rick Porcello’s Strong Start Gives Boost to Red Sox
Two Bench Clearing Incidents Revive Red Sox-Yankees Rivalry
Two Bench Clearing Incidents Revive Red Sox-Yankees Rivalry
Xander Bogaerts Goes on Red Sox DL
Xander Bogaerts Goes on Red Sox DL


Leave a Reply

 
© 2006-2018 BBNS.